1. DROSSMAN DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 ; 130 (5) : 1377-90.
2. QUIGLEY EM et al. AGA technical review on nausea and vomiting. Gastroenterology. 2001 ; 120 (1) : 263-86.
3. LOCKE GR et al. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology. 2000 ; 119 (6) : 1766-78.
4. DROSSMAN DA et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 ; 123 (6) : 2108-31.
5. CHADWICK VS et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002 ; 122 (7) : 1778-83.
6. BARBARA G et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004 ; 126 (3) : 693-702.
7. GERSHON MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol. 2005 ; 39 (5 Suppl 3) : S184-S193.
8. DUNLOP SP et al. Abnormalities of 5- hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 ; 3 (4) : 349-57.
9. STAM R et al. Long-lasting changes in central nervous system responsivity to colonic distention after stress in rats. Gastroenterology. 2002 ; 123 (4) : 1216-25.
10. FORD AC, TALLEY NJ.Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011 ; 46 (4) : 421-31.
11. GHOSHAL UC, RANJAN P. Postinfectious irritable bowel syndrome: the past, the present and the future. J Gastroenterol Hepatol. 2011 ; 26 Suppl 3 : 94-101.
12. SVENSSON TH. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology (Berl). 1987 ; 92 (1) : 1-7.
13. VALORI RM et al. Effects of different types of stress and of «prokinetic» drugs on the control of the fasting motor complex in humans. Gastroenterology. 1986 ; 90 (6) : 1890-900.
14. MURRAY CD et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology. 2004 ; 127 (6) : 1695-703.
15. JONES MP et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006 ; 18 (2) : 91-103.
16. CASES J et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011 ; 4 (3) : 211-8.
17. CERNY A, SCHMID KW. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study). Fitoterapia. 1999 ; 70 : 221-8.
18. SOULIMANI R et al. Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta Medica. 1991 ; 57 : 105-9.
19. IBARRA A et al. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010 ; 17(6) : 397-403.
20.KENNEDY DO et al.Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002 ; 72 (4) : 953- 64.
21. AKHONDZADEH S et al. Melissa officinalis extract in the treatment of patients with mild to moderate
Alzheimer’s disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003 ; 74 (7) : 863-6.
22.WAKE G et al. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol. 2000 ; 69 (2) : 105-14.
23. REITER M, BRANDT W. Relaxant effects on tracheal and ileal smooth muscles of the guinea pig. Arzneimittelforschung. 1985 ; 35 (1A) : 408-14.
24. SADRAEI H et al. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia. 2003 ; 74 (5) : 445-52.
25. VEJDANI R et al. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study. Dig Dis Sci. 2006 ; 51 (8) : 1501-7.
26.KHAYYAL MT et al. Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. Arzneimittelforschung. 2001 ; 51 (7) : 545-53.
27. BOLKENT S et al. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study. J Ethnopharmacol. 2005 ; 99 (3) : 391-8.
28. LEE J al. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol. 2008 ; 115 (2) : 263-70.
29. LARRONDO JV et al. Antimicrobial activity of essences from labiates. Microbios. 1995 ; 82 (332) : 171-2.
30.MIKUS J et al. In vitro effect of essential oils and isolated mono and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 2000 ; 66 (4) : 366-8.
31. ASTANI A et al.Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy. 2012 ; 58 (1) : 70-7.
32.MAZZANTI G et al. Inhibitory activity of Melissa officinalis L. extract on Herpes simplex virus type 2 replication. Nat Prod Res. 2008 ; 22 (16) : 1433-40.
33. LAMAISON JL et al. [Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid]. Pharm Acta Helv. 1991 ; 66 (7) : 185-8.
34. SPIRIDON I et al. Antioxidant capacity and total phenolic contents of oregano (Origanum vulgare), lavender (Lavandula angustifolia) and lemon balm (Melissa officinalis) from Romania. Nat Prod Res. 2011 ; 25 (17) : 1657-61.
35. PEREIRA RP et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res. 2009 ; 34 (5) : 973-83.
36.MARTINS EN et al. Protective effect of Melissa officinalis aqueous extract against Mninduced oxidative stress in chronically exposed mice. Brain Res Bull. 2012 ; 87 (1) : 74-9.
37. ZERAATPISHE A et al. Effects of Melissa officinalis L. on oxidative
status and DNA damage in subjects exposed to long-term low-dose ionizing radiation. Toxicol Ind Health. 2011 ; 27 (3) : 205-12.